Association between adherence to guideline-recommended preventive medications and in-hospital mortality among non-reperfused ST-elevation myocardial infarction patients admitted to a tertiary care academic center in a developing country

Sylvi Irawati; Surya Dharma; Katja Taxis; null Nguyen Thang; Nunung Nursyarofah; Bob Wilffert; Eelko Hak

Association between adherence to guideline-recommended preventive medications and in-hospital mortality among non-reperfused ST-elevation myocardial infarction patients admitted to a tertiary care academic center in a developing country

Sylvi Irawati, Surya Dharma, Katja Taxis, Nguyen Thang, Nunung Nursyarofah, Bob Wilffert, Eelko Hak

Research output: Contribution to journal › Meeting Abstract › Academic

Original language	English
Pages (from-to)	525-525
Number of pages	1
Journal	Pharmacoepidemiology and Drug Safety
Volume	28
Publication status	Published - Aug-2019

Cite this

Irawati, S., Dharma, S., Taxis, K., Nguyen Thang, Nursyarofah, N., Wilffert, B., & Hak, E. (2019). Association between adherence to guideline-recommended preventive medications and in-hospital mortality among non-reperfused ST-elevation myocardial infarction patients admitted to a tertiary care academic center in a developing country. Pharmacoepidemiology and Drug Safety, 28, 525-525.

Irawati, Sylvi ; Dharma, Surya ; Taxis, Katja ; Nguyen Thang ; Nursyarofah, Nunung ; Wilffert, Bob ; Hak, Eelko. / Association between adherence to guideline-recommended preventive medications and in-hospital mortality among non-reperfused ST-elevation myocardial infarction patients admitted to a tertiary care academic center in a developing country. In: Pharmacoepidemiology and Drug Safety. 2019 ; Vol. 28. pp. 525-525.

@article{3048c88ea3da48939f8eb8881a62238f,

title = "Association between adherence to guideline-recommended preventive medications and in-hospital mortality among non-reperfused ST-elevation myocardial infarction patients admitted to a tertiary care academic center in a developing country",

author = "Sylvi Irawati and Surya Dharma and Katja Taxis and {Nguyen Thang} and Nunung Nursyarofah and Bob Wilffert and Eelko Hak",

year = "2019",

month = aug,

language = "English",

volume = "28",

pages = "525--525",

journal = "Pharmcoepidemiology and Drug Safety",

issn = "1053-8569",

publisher = "Wiley",

}

Irawati, S, Dharma, S, Taxis, K, Nguyen Thang, Nursyarofah, N, Wilffert, B & Hak, E 2019, 'Association between adherence to guideline-recommended preventive medications and in-hospital mortality among non-reperfused ST-elevation myocardial infarction patients admitted to a tertiary care academic center in a developing country', Pharmacoepidemiology and Drug Safety, vol. 28, pp. 525-525.

Association between adherence to guideline-recommended preventive medications and in-hospital mortality among non-reperfused ST-elevation myocardial infarction patients admitted to a tertiary care academic center in a developing country. / Irawati, Sylvi; Dharma, Surya; Taxis, Katja; Nguyen Thang; Nursyarofah, Nunung; Wilffert, Bob ; Hak, Eelko.

In: Pharmacoepidemiology and Drug Safety, Vol. 28, 08.2019, p. 525-525.

Research output: Contribution to journal › Meeting Abstract › Academic

TY - JOUR

T1 - Association between adherence to guideline-recommended preventive medications and in-hospital mortality among non-reperfused ST-elevation myocardial infarction patients admitted to a tertiary care academic center in a developing country

AU - Irawati, Sylvi

AU - Dharma, Surya

AU - Taxis, Katja

AU - Nguyen Thang, null

AU - Nursyarofah, Nunung

AU - Wilffert, Bob

AU - Hak, Eelko

PY - 2019/8

Y1 - 2019/8

M3 - Meeting Abstract

VL - 28

SP - 525

EP - 525

JO - Pharmcoepidemiology and Drug Safety

JF - Pharmcoepidemiology and Drug Safety

SN - 1053-8569

ER -

Irawati S, Dharma S, Taxis K, Nguyen Thang, Nursyarofah N, Wilffert B et al. Association between adherence to guideline-recommended preventive medications and in-hospital mortality among non-reperfused ST-elevation myocardial infarction patients admitted to a tertiary care academic center in a developing country. Pharmacoepidemiology and Drug Safety. 2019 Aug;28:525-525.